QQQ   430.00 (-0.25%)
AAPL   172.54 (-0.09%)
MSFT   413.88 (+0.06%)
META   497.97 (-0.45%)
GOOGL   154.01 (-0.55%)
AMZN   182.71 (-0.50%)
TSLA   154.95 (-4.04%)
NVDA   862.12 (+0.25%)
AMD   162.51 (+1.37%)
NIO   3.72 (-4.37%)
BABA   69.60 (-1.44%)
T   16.07 (-1.05%)
F   12.04 (-1.55%)
MU   118.76 (-2.15%)
GE   153.79 (+0.06%)
CGC   6.82 (-2.29%)
DIS   112.80 (-0.13%)
AMC   2.51 (+1.62%)
PFE   25.84 (-0.27%)
PYPL   62.96 (-0.87%)
XOM   119.51 (-0.14%)
QQQ   430.00 (-0.25%)
AAPL   172.54 (-0.09%)
MSFT   413.88 (+0.06%)
META   497.97 (-0.45%)
GOOGL   154.01 (-0.55%)
AMZN   182.71 (-0.50%)
TSLA   154.95 (-4.04%)
NVDA   862.12 (+0.25%)
AMD   162.51 (+1.37%)
NIO   3.72 (-4.37%)
BABA   69.60 (-1.44%)
T   16.07 (-1.05%)
F   12.04 (-1.55%)
MU   118.76 (-2.15%)
GE   153.79 (+0.06%)
CGC   6.82 (-2.29%)
DIS   112.80 (-0.13%)
AMC   2.51 (+1.62%)
PFE   25.84 (-0.27%)
PYPL   62.96 (-0.87%)
XOM   119.51 (-0.14%)
QQQ   430.00 (-0.25%)
AAPL   172.54 (-0.09%)
MSFT   413.88 (+0.06%)
META   497.97 (-0.45%)
GOOGL   154.01 (-0.55%)
AMZN   182.71 (-0.50%)
TSLA   154.95 (-4.04%)
NVDA   862.12 (+0.25%)
AMD   162.51 (+1.37%)
NIO   3.72 (-4.37%)
BABA   69.60 (-1.44%)
T   16.07 (-1.05%)
F   12.04 (-1.55%)
MU   118.76 (-2.15%)
GE   153.79 (+0.06%)
CGC   6.82 (-2.29%)
DIS   112.80 (-0.13%)
AMC   2.51 (+1.62%)
PFE   25.84 (-0.27%)
PYPL   62.96 (-0.87%)
XOM   119.51 (-0.14%)
QQQ   430.00 (-0.25%)
AAPL   172.54 (-0.09%)
MSFT   413.88 (+0.06%)
META   497.97 (-0.45%)
GOOGL   154.01 (-0.55%)
AMZN   182.71 (-0.50%)
TSLA   154.95 (-4.04%)
NVDA   862.12 (+0.25%)
AMD   162.51 (+1.37%)
NIO   3.72 (-4.37%)
BABA   69.60 (-1.44%)
T   16.07 (-1.05%)
F   12.04 (-1.55%)
MU   118.76 (-2.15%)
GE   153.79 (+0.06%)
CGC   6.82 (-2.29%)
DIS   112.80 (-0.13%)
AMC   2.51 (+1.62%)
PFE   25.84 (-0.27%)
PYPL   62.96 (-0.87%)
XOM   119.51 (-0.14%)

Organogenesis (ORGO) Earnings Date, Estimates & Call Transcripts

$2.79
+0.03 (+1.09%)
(As of 09:45 AM ET)
Skip Charts & View Estimated and Actual Earnings Data

ORGO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ORGO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Organogenesis Analyst EPS Estimates

Current Year EPS Consensus Estimate:($0.01) EPS

ORGO Earnings Date and Information

Organogenesis has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 8th, 2024 based off prior year's report dates.

Organogenesis Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/8/2024
Estimated)
------- 
11/9/2023Q3 2023$0.01$0.02+$0.01$0.02$112.75 million$108.53 million
8/9/2023Q2 2023$0.02$0.04+$0.02$0.04$115.25 million$117.32 million
5/10/2023Q1 2023-($0.02)($0.02)($0.02)-$107.64 million
3/1/2023Q4 2022-$0.06+$0.06$0.06-$115.52 million
11/9/2022Q3 2022$0.06$0.04($0.02)$0.08$121.40 million$116.86 million
8/9/2022Q2 2022$0.08$0.09+$0.01$0.11$121.00 million$121.40 million
5/10/2022Q1 2022$0.05$0.01($0.04)$0.02$96.15 million$98.12 million    
3/1/2022Q4 2021$0.08$0.41+$0.33$0.43$124.35 million$128.56 million
11/9/2021Q3 2021$0.06$0.09+$0.03$0.09$112.10 million$113.75 million    
8/9/2021Q2 2021$0.06$0.15+$0.09$0.15$105.65 million$123.20 million    
5/10/2021Q1 2021($0.04)$0.07+$0.11$0.07$86.30 million$102.55 million  

Organogenesis Earnings - Frequently Asked Questions

When is Organogenesis's earnings date?

Organogenesis has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 8th, 2024 based off last year's report dates. Learn more on ORGO's earnings history.

How much revenue does Organogenesis generate each year?

Organogenesis (NASDAQ:ORGO) has a recorded annual revenue of $433.14 million.

How much profit does Organogenesis generate each year?

Organogenesis (NASDAQ:ORGO) has a recorded net income of $4.95 million. ORGO has generated $0.04 earnings per share over the last four quarters.

What is Organogenesis's price-to-earnings ratio?

Organogenesis (NASDAQ:ORGO) has a trailing price-to-earnings ratio of 69.02.


More Earnings Resources from MarketBeat

This page (NASDAQ:ORGO) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners